World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scientific Indexing Services (SIS), Indian citation Index (ICI), Directory of Research Journals Indexing, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Cosmos Impact Factor, IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, 

Abstract

USE OF LETROZOLE FOR INFERTILITY IN THE POLYCYSTIC OVARY SYNDROME

Rokeya Ferdousey*, Rehana Parvin, Shahin Rahman Chowdhury and Dr. Morshed Nasir

ABSTRACT

Introduction: The polycystic ovary syndrome is a common cause of infertility. Letrozole, a third generation aromatase inhibitor, is now considered as the best alternative of clomiphene citrate for the infertility treatment in women with the polycystic ovary syndrome. Objective: To observed effect of letrozole therapy in infertile women with polycystic ovary syndrome. Methodology: In this cross-sectional study we enrolled 310 infertile women aged 20-35 years diagnosed as polycystic ovary syndrome. Participants who had normal uterine cavity and sperm concentration of at least 20 million/ml of her husband were prescribed letrozole for 6 months. Medication was discontinued when pregnancy was confirmed and participants were followed untill delivery. Results: After 6 months treatment 125 (40.5%) patient was conceived. Live birth was 65 (20.9%) of 310 subjects. Among pregnancies multiple (twin) birth was 18 (5.7%). First trimester pregnancy loss was 61(19.5%). After having 6 months of therapy there was no pregnancy in 185 (59.5%) patients. Conclusions: Letrozole is safe and cost effective medicine in achieving live birth in infertile women with polycystic ovary syndrome.

[Full Text Article]   [Download Certificate]

WJPLS CITATION

  All Since 2019
 Citation  422  322
 h-index  9  7
 i10-index  4  2

INDEXING

NEWS & UPDATION

    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79

BEST PAPER AWARDS

World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here